5-(4-溴苯基)-2-(4-硝基苯基)噁唑结构式
|
常用名 | 5-(4-溴苯基)-2-(4-硝基苯基)噁唑 | 英文名 | 5-(4-BROMO-PHENYL)-2-(4-NITRO-PHENYL)-OXAZOLE |
|---|---|---|---|---|
| CAS号 | 118426-04-3 | 分子量 | 345.14800 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C15H9BrN2O3 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
摘要:5-(4-溴苯基)-2-(4-硝基苯基)噁唑(中文名称)是一种化学物质,其英文名称为5-(4-bromophenyl)-2-(4-nitrophenyl)-1,3-oxazole(CAS号:118426-04-3),分子式为C15H9BrN2O3,分子量为345.14800。仅供科研实验参考,不作为医疗诊断与用药依据。
本表展示该化学物质的中文名称、英文系统名、各类中文与英文别名信息。
| 中文名 | 5-(4-溴苯基)-2-(4-硝基苯基)噁唑 |
|---|---|
| 英文名 | 5-(4-bromophenyl)-2-(4-nitrophenyl)-1,3-oxazole |
| 英文别名 | 更多 |
本表包含该物质理化参数,如熔点、沸点、密度、溶解度、旋光性等理化指标,无数据项标记为N/A。
| 分子式 | C15H9BrN2O3 |
|---|---|
| 分子量 | 345.14800 |
| 精确质量 | 343.98000 |
| PSA | 71.85000 |
| LogP | 5.20250 |
| InChIKey | HQFYSZAPVRHQNX-UHFFFAOYSA-N |
| SMILES | O=[N+]([O-])c1ccc(-c2ncc(-c3ccc(Br)cc3)o2)cc1 |
本表提供该化合物公开报道的合成路线、反应条件、反应物与产物参考信息。
|
~90%
5-(4-溴苯基)-2-(4-... 118426-04-3 |
| 文献:Shvaika, O. P.; Korzhenevskaya, N. G.; Snagoshchenko, L. P. Chemistry of Heterocyclic Compounds (New York, NY, United States), 1985 , vol. 21, # 2 p. 157 - 160 Khimiya Geterotsiklicheskikh Soedinenii, 1985 , vol. 21, # 2 p. 193 - 197 |
|
~31%
5-(4-溴苯基)-2-(4-... 118426-04-3 |
| 文献:Haldon, Estela; Besora, Maria; Cano, Israel; Cambeiro, Xacobe C.; Pericas, Miquel A.; Maseras, Feliu; Nicasio, M. Carmen; Perez, Pedro J. Chemistry - A European Journal, 2014 , vol. 20, # 12 p. 3463 - 3474 |
|
~%
5-(4-溴苯基)-2-(4-... 118426-04-3 |
| 文献:BRISTOL-MYERS SQUIBB COMPANY; LOPEZ, Omar D.; ST. LAURENT, Denis R.; GOODRICH, Jason; ROMINE, Jeffrey Lee; SERRANO-WU, Michael; YANG, Fukang; KAKARLA, Ramesh; YANG, Xuejie; QIU, Yuping; SNYDER, Lawrence B. Patent: WO2011/82077 A1, 2011 ; |
|
~%
5-(4-溴苯基)-2-(4-... 118426-04-3 |
| 文献:BRISTOL-MYERS SQUIBB COMPANY; LOPEZ, Omar D.; ST. LAURENT, Denis R.; GOODRICH, Jason; ROMINE, Jeffrey Lee; SERRANO-WU, Michael; YANG, Fukang; KAKARLA, Ramesh; YANG, Xuejie; QIU, Yuping; SNYDER, Lawrence B. Patent: WO2011/82077 A1, 2011 ; |
本表记录该化合物靶点、体外体内实验、生物测定实验相关实验数据。
|
实验名称:Primary cell-based high-throughput screening assay for identification of compounds th...
来源:Johns Hopkins Ion Channel Center
靶标:regulator of G-protein signaling 4 isoform 2 [Homo sapiens]
External Id:JHICC_RGS_Act_HTS
|
|
实验名称:Luminescence-based cell-based primary high throughput screening assay to identify ago...
来源:The Scripps Research Institute Molecular Screening Center
靶标:mu-type opioid receptor isoform MOR-1 [Homo sapiens]
External Id:OPRM1-OPRD1_AG_LUMI_1536_1X%ACT PRUN
|
|
实验名称:QFRET-based biochemical primary high throughput screening assay to identify exosite i...
来源:The Scripps Research Institute Molecular Screening Center
靶标:disintegrin and metalloproteinase domain-containing protein 17 preproprotein [Homo sapiens]
External Id:ADAM17_INH_QFRET_1536_1X%INH PRUN
|
|
实验名称:Fluorescence-based cell-based primary high throughput screening assay to identify ago...
来源:The Scripps Research Institute Molecular Screening Center
靶标:muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id:CHRM1_AG_FLUO8_1536_1X%ACT PRUN
|
|
实验名称:uHTS identification of small molecule activators of the adaptive arm of the Unfolded ...
来源:Burnham Center for Chemical Genomics
靶标:N/A
External Id:BCCG-A405-UPR-XBP1-PrimaryAgonist-Assay
|
|
实验名称:Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); ...
来源:ChEMBL
靶标:Klebsiella pneumoniae
External Id:CHEMBL4296186
|
|
实验名称:High throughput fluorescence intensity-based biochemical assay to screen for small mo...
来源:University of Pittsburgh Molecular Library Screening Center
靶标:furin (paired basic amino acid cleaving enzyme), isoform CRA_a [Homo sapiens]
External Id:MH080376 Biochemical HTS for Inhibitors of the Proprotein Convertase Furin.
|
|
实验名称:Fluorescence polarization to screen for inhibitor that competite the binding of FadD2...
来源:Broad Institute
靶标:FATTY-ACID-CoA LIGASE FADD28 (FATTY-ACID-CoA SYNTHETASE)
External Id:2147-01_Inhibitor_SinglePoint_HTS_Activity
|
|
实验名称:Bursicon-induced LGR2 mediated cAMP production in LGR-2/CRE6x-Luciferase co-transfect...
来源:Broad Institute
靶标:N/A
External Id:Bursicon-induced LGR2 mediated cAMP production in LGR-2/CRE6x-Luciferase co-transfected HEK293 cells Inhibition - 7011-01_Antagonist_SinglePoint_HTS_Activity
|
|
实验名称:Identifying Sarm1 TIR NADase inhibitors through high throughput HPLC assay
来源:24386
靶标:N/A
External Id:Sarm1 TIR NADase inhibitors
|
本表罗列该化合物全部英文别名、系统命名、CAS别名等英文名称集合。
| 2-(4-nitrophenyl)-5-(4-bromophenyl)oxazole |
| 5-(4-bromophenyl)-2-(4-nitrophenyl)oxazole |
本部分为该化合物相关常见问答,包含基础参数、性状、储存条件等高频咨询问题与对应答案。
| Q: 5-(4-溴苯基)-2-(4-硝基苯基)噁唑的CAS号是多少? |
| A: 5-(4-溴苯基)-2-(4-硝基苯基)噁唑CAS号为118426-04-3。 |
| Q: 118426-04-3的中文名称是什么? |
| A: 118426-04-3的中文名称为5-(4-溴苯基)-2-(4-硝基苯基)噁唑。 |
| Q: 5-(4-溴苯基)-2-(4-硝基苯基)噁唑有哪些英文别名? |
| A: 5-(4-溴苯基)-2-(4-硝基苯基)噁唑英文别名有:2-(4-nitrophenyl)-5-(4-bromophenyl)oxazole、 5-(4-bromophenyl)-2-(4-nitrophenyl)oxazole。 |
| Q: 5-(4-溴苯基)-2-(4-硝基苯基)噁唑的极性表面积PSA是多少? |
| A: 5-(4-溴苯基)-2-(4-硝基苯基)噁唑极性表面积PSA为71.85000。 |
| Q: 5-(4-溴苯基)-2-(4-硝基苯基)噁唑的LogP(油水分配系数)是多少? |
| A: 5-(4-溴苯基)-2-(4-硝基苯基)噁唑LogP(油水分配系数)为5.20250。 |
| Q: 5-(4-溴苯基)-2-(4-硝基苯基)噁唑的InChIKey是什么? |
| A: 5-(4-溴苯基)-2-(4-硝基苯基)噁唑InChIKey为HQFYSZAPVRHQNX-UHFFFAOYSA-N。 |
| Q: 5-(4-溴苯基)-2-(4-硝基苯基)噁唑的分子量是多少? |
| A: 5-(4-溴苯基)-2-(4-硝基苯基)噁唑分子量为345.14800。 |
| Q: 5-(4-溴苯基)-2-(4-硝基苯基)噁唑的SMILES表达式是什么? |
| A: 5-(4-溴苯基)-2-(4-硝基苯基)噁唑SMILES表达式为O=[N+]([O-])c1ccc(-c2ncc(-c3ccc(Br)cc3)o2)cc1。 |
| Q: 5-(4-溴苯基)-2-(4-硝基苯基)噁唑的英文名称是什么? |
| A: 5-(4-溴苯基)-2-(4-硝基苯基)噁唑英文名称为5-(4-bromophenyl)-2-(4-nitrophenyl)-1,3-oxazole。 |
| Q: 5-(4-溴苯基)-2-(4-硝基苯基)噁唑的分子式是什么? |
| A: 5-(4-溴苯基)-2-(4-硝基苯基)噁唑分子式为C15H9BrN2O3。 |